MedEquities Realty Trust (MRT) Upgraded to “Neutral” at Citigroup

Share on StockTwits

Citigroup upgraded shares of MedEquities Realty Trust (NYSE:MRT) from a sell rating to a neutral rating in a research note published on Monday, MarketBeat.com reports. Citigroup currently has $9.00 target price on the financial services provider’s stock.

A number of other brokerages have also issued reports on MRT. KeyCorp lowered MedEquities Realty Trust from an overweight rating to a hold rating and set a $12.00 price target on the stock. in a research note on Wednesday, August 8th. Zacks Investment Research lowered MedEquities Realty Trust from a buy rating to a hold rating in a research note on Saturday, August 11th. JMP Securities set a $12.00 price target on MedEquities Realty Trust and gave the stock a buy rating in a research note on Tuesday, October 23rd. ValuEngine lowered MedEquities Realty Trust from a sell rating to a strong sell rating in a research note on Wednesday, August 8th. Finally, Royal Bank of Canada set a $10.00 price target on MedEquities Realty Trust and gave the stock a hold rating in a research note on Sunday, August 12th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the company. The stock has a consensus rating of Hold and an average price target of $11.13.

MedEquities Realty Trust stock opened at $7.53 on Monday. The stock has a market cap of $245.66 million, a P/E ratio of 6.61 and a beta of 0.65. MedEquities Realty Trust has a 52 week low of $7.33 and a 52 week high of $12.00.

MedEquities Realty Trust (NYSE:MRT) last posted its quarterly earnings data on Monday, November 12th. The financial services provider reported ($0.07) EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.25). MedEquities Realty Trust had a return on equity of 3.39% and a net margin of 19.98%. The company had revenue of $9.68 million for the quarter, compared to analysts’ expectations of $17.72 million. As a group, analysts expect that MedEquities Realty Trust will post 1.08 earnings per share for the current year.

In other MedEquities Realty Trust news, Director Bluemountain Capital Managemen sold 3,955 shares of the firm’s stock in a transaction dated Friday, October 5th. The stock was sold at an average price of $9.13, for a total value of $36,109.15. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last three months, insiders sold 328,328 shares of company stock worth $2,801,410. 2.50% of the stock is owned by corporate insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. AQR Capital Management LLC lifted its stake in shares of MedEquities Realty Trust by 94.3% in the 3rd quarter. AQR Capital Management LLC now owns 132,341 shares of the financial services provider’s stock valued at $1,286,000 after purchasing an additional 64,221 shares in the last quarter. MetLife Investment Advisors LLC lifted its stake in shares of MedEquities Realty Trust by 65.1% in the 3rd quarter. MetLife Investment Advisors LLC now owns 17,683 shares of the financial services provider’s stock valued at $172,000 after purchasing an additional 6,974 shares in the last quarter. Putnam Investments LLC lifted its stake in shares of MedEquities Realty Trust by 664.8% in the 3rd quarter. Putnam Investments LLC now owns 178,190 shares of the financial services provider’s stock valued at $1,732,000 after purchasing an additional 154,890 shares in the last quarter. Aristotle Capital Boston LLC lifted its stake in shares of MedEquities Realty Trust by 9.4% in the 3rd quarter. Aristotle Capital Boston LLC now owns 1,003,724 shares of the financial services provider’s stock valued at $9,756,000 after purchasing an additional 86,324 shares in the last quarter. Finally, Renaissance Technologies LLC lifted its stake in shares of MedEquities Realty Trust by 21.5% in the 3rd quarter. Renaissance Technologies LLC now owns 1,020,302 shares of the financial services provider’s stock valued at $9,917,000 after purchasing an additional 180,502 shares in the last quarter. 91.60% of the stock is currently owned by institutional investors and hedge funds.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Featured Story: How can investors find ex-dividend dates?

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply